|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
31,570,000 |
Market
Cap: |
7.49(M) |
Last
Volume: |
540,567 |
Avg
Vol: |
535,506 |
52
Week Range: |
$0.1483 - $0.94 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile BrainStorm Cell Therapeutics is a biotechnology company engaged in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases including: Amyotrophic Lateral Sclerosis; Progressive Multiple Sclerosis; Alzheimer's disease; and other neurodegenerative diseases. NurOwn®, Co.'s proprietary platform, utilizes cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival and improve neurological function.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
566,372 |
566,372 |
577,872 |
Total Buy Value |
$0 |
$271,807 |
$271,807 |
$292,209 |
Total People Bought |
0 |
1 |
1 |
2 |
Total Buy Transactions |
0 |
11 |
11 |
12 |
Total Shares Sold |
63,000 |
63,000 |
63,000 |
63,000 |
Total Sell Value |
$22,069 |
$22,069 |
$22,069 |
$22,069 |
Total People Sold |
1 |
1 |
1 |
1 |
Total Sell Transactions |
1 |
1 |
1 |
1 |
End Date |
2024-06-23 |
2024-03-22 |
2023-09-22 |
2022-09-22 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Setboun David |
EVP and COO |
|
2020-07-16 |
4 |
B |
$12.95 |
$64,740 |
D/D |
5,000 |
55,000 |
2.74 |
- |
|
Acc International Holdings Ltd. |
Member of 10% owner group |
|
2020-07-15 |
4 |
S |
$13.12 |
$241,715 |
D/D |
(18,430) |
74,876 |
|
- |
|
Abbhi Sankesh |
Director |
|
2020-07-15 |
4 |
B |
$12.99 |
$607,659 |
I/I |
46,779 |
2,164,530 |
2.1 |
- |
|
Acc International Holdings Ltd. |
Member of 10% owner group |
|
2020-07-13 |
4 |
S |
$13.52 |
$540,952 |
D/D |
(40,000) |
93,306 |
|
- |
|
Acc International Holdings Ltd. |
Member of 10% owner group |
|
2020-07-10 |
4 |
S |
$13.35 |
$26,700 |
D/D |
(2,000) |
133,306 |
|
- |
|
Acc International Holdings Ltd. |
Member of 10% owner group |
|
2020-07-09 |
4 |
S |
$13.13 |
$45,939 |
D/D |
(3,500) |
135,306 |
|
- |
|
Yablonka Uri |
EVP & Chief Business Officer |
|
2020-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
17,543 |
|
- |
|
Lindborg Stacy |
EVP, Head Global Clin Research |
|
2020-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
|
- |
|
Setboun David |
EVP and COO |
|
2020-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
Abbhi Sankesh |
Director |
|
2020-04-06 |
4 |
A |
$0.00 |
$0 |
D/D |
4,657 |
4,657 |
|
- |
|
Abbhi Sankesh |
Director |
|
2020-03-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,117,751 |
|
- |
|
Kern Ralph Dr. |
COO and Chief Medical Officer |
|
2020-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
35,885 |
151,540 |
|
- |
|
Polverino Anthony J. |
Director |
|
2020-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,071 |
15,862 |
|
- |
|
Kern Ralph Dr. |
COO and Chief Medical Officer |
|
2019-12-24 |
4 |
B |
$3.88 |
$11,640 |
D/D |
3,000 |
115,655 |
2.74 |
- |
|
Shah Preetam |
EVP, CFO and Treasurer |
|
2019-12-24 |
4 |
B |
$3.96 |
$45,929 |
D/D |
11,600 |
36,600 |
2.74 |
- |
|
Araya Arturo |
Chief Commercial Officer |
|
2019-12-24 |
4 |
B |
$3.90 |
$11,700 |
D/D |
3,000 |
8,608 |
2.74 |
- |
|
Polverino Anthony J. |
Director |
|
2019-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
12,791 |
|
- |
|
Taub Malcolm S |
Director |
|
2019-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
53,332 |
|
- |
|
Almenoff June Sherie |
Director |
|
2019-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
2,000 |
|
- |
|
Shah Preetam |
EVP, CFO and Treasurer |
|
2019-09-06 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
|
- |
|
Arbel Irit |
Director |
|
2019-08-28 |
4 |
S |
$3.67 |
$48,891 |
D/D |
(13,332) |
155,833 |
|
- |
|
Arbel Irit |
Director |
|
2019-08-28 |
4 |
OE |
$2.25 |
$29,997 |
D/D |
13,332 |
169,165 |
|
- |
|
Lebovits Chaim |
See Remarks |
|
2019-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
31,185 |
2,166,155 |
|
- |
|
Kern Ralph Dr. |
COO and Chief Medical Officer |
|
2019-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
35,885 |
112,655 |
|
- |
|
Polverino Anthony J. |
Director |
|
2019-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,501 |
10,791 |
|
- |
|
131 Records found
|
|
Page 3 of 6 |
|
|